Literature DB >> 8757214

Cytokines directly induce degranulation and superoxide production from human eosinophils.

S Horie1, G J Gleich, H Kita.   

Abstract

BACKGROUND: Cytokines are implicated in allergic diseases and can modulate effector functions of eosinophils stimulated by another agonist. However, little is known about the capacity of cytokines to directly trigger eosinophil degranulation.
OBJECTIVES: We attempted to determine whether cytokines can directly induce degranulation and superoxide production from eosinophils.
METHODS: Eosinophils from normal donors were incubated with various cytokines in albumin-coated tissue culture plates for 4 hours. To quantitate degranulation, the amounts of eosinophil-derived neurotoxin in supernatants were measured by radioimmunoassay. In addition, superoxide production was measured by superoxide dismutase-inhibitable reduction of cytochrome c.
RESULTS: IL-5, IL-3, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor- alpha, and RANTES all induced eosinophil degranulation. Granulocyte-macrophage colony-stimulating factor was the most potent and induced eosinophil-derived neurotoxin release comparable to that induced by secretory IgA beads, one of the most potent secretagogues for eosinophils. In addition, IL-5 and tumor necrosis factor- alpha were synergistic in their induction of eosinophil degranulation. In contrast, IL-1, IL-8, interferon- gamma, and macrophage inflammatory protein-1 alpha did not induce degranulation. Finally, IL-5, IL-3, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor- alpha, but not RANTES, also induced superoxide production from eosinophils.
CONCLUSIONS: Certain cytokines directly induce eosinophil degranulation and superoxide production in vitro. Therefore these cytokines may be important in the release of toxic granule proteins from eosinophils in allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757214     DOI: 10.1016/s0091-6749(96)70161-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

1.  Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G.

Authors:  M H Shin; H Kita; H Y Park; J Y Seoh
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Eosinophil-mediated tissue inflammatory responses in helminth infection.

Authors:  Myeong Heon Shin; Young Ah Lee; Duk-Young Min
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

3.  Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP.

Authors:  Takehito Kobayashi; Hideaki Kouzaki; Hirohito Kita
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

4.  Eosinophils regulate peripheral B cell numbers in both mice and humans.

Authors:  Tina W Wong; Alfred D Doyle; James J Lee; Diane F Jelinek
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

5.  Degranulation of human eosinophils induced by Paragonimus westermani-secreted protease.

Authors:  Myeong Heon Shin; Young-Bae Chung; Hirohito Kita
Journal:  Korean J Parasitol       Date:  2005-03       Impact factor: 1.341

6.  Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics.

Authors:  J R Velazquez; P Lacy; R Moqbel
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

7.  Development of cellular immune response of mice to infection with low doses of Trichinella spiralis, Trichinella britovi and Trichinella pseudospiralis larvae.

Authors:  Emília Dvorožňáková; Zuzana Hurníková; Marta Kołodziej-Sobocińska
Journal:  Parasitol Res       Date:  2010-10-22       Impact factor: 2.289

Review 8.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

9.  Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils.

Authors:  Mary Ellen Bates; Julie B Sedgwick; Yiming Zhu; Lin Ying Liu; Rose G Heuser; Nizar N Jarjour; Hirohito Kita; Paul J Bertics
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

10.  Pimecrolimus reduces eosinophil activation associated with calcium mobilization.

Authors:  Douglas A Plager; Susan A Henke; Yoshinori Matsuwaki; Arvind Madaan; Diane L Squillace; Ross A Dierkhising; Hirohito Kita
Journal:  Int Arch Allergy Immunol       Date:  2009-01-06       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.